SCAGNOLARI, CAROLINA
 Distribuzione geografica
Continente #
NA - Nord America 6.874
EU - Europa 2.259
AS - Asia 742
AF - Africa 84
SA - Sud America 49
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 10.012
Nazione #
US - Stati Uniti d'America 6.824
IT - Italia 1.062
CN - Cina 338
IN - India 308
SE - Svezia 292
FI - Finlandia 207
UA - Ucraina 160
IE - Irlanda 115
DE - Germania 95
BG - Bulgaria 70
TG - Togo 67
RO - Romania 59
CA - Canada 50
GB - Regno Unito 50
BE - Belgio 44
AR - Argentina 42
MY - Malesia 39
FR - Francia 38
SG - Singapore 33
NL - Olanda 19
HK - Hong Kong 10
AT - Austria 7
CH - Svizzera 7
ZA - Sudafrica 6
PL - Polonia 5
SC - Seychelles 5
CL - Cile 4
RS - Serbia 4
TR - Turchia 4
VA - Santa Sede (Città del Vaticano) 4
BA - Bosnia-Erzegovina 3
GR - Grecia 3
HR - Croazia 3
PE - Perù 3
AU - Australia 2
BY - Bielorussia 2
CY - Cipro 2
CZ - Repubblica Ceca 2
ES - Italia 2
EU - Europa 2
MG - Madagascar 2
PH - Filippine 2
RU - Federazione Russa 2
ZM - Zambia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
ID - Indonesia 1
IR - Iran 1
IS - Islanda 1
JP - Giappone 1
KG - Kirghizistan 1
NG - Nigeria 1
NO - Norvegia 1
PT - Portogallo 1
SA - Arabia Saudita 1
TN - Tunisia 1
Totale 10.012
Città #
Fairfield 1.100
Chandler 586
Ashburn 516
Woodbridge 458
Rome 419
Seattle 394
Houston 389
Cambridge 328
Wilmington 324
Dearborn 297
Ann Arbor 296
Princeton 196
San Paolo di Civitate 154
Plano 126
Beijing 121
Dublin 115
Lawrence 114
Fremont 106
Millbury 98
Helsinki 95
Boston 84
Sofia 70
Bremen 69
Lomé 67
San Diego 65
Andover 56
Jacksonville 52
Brussels 44
New York 44
Federal 42
Boardman 35
Des Moines 35
Horia 35
Milan 35
Norwalk 29
Nanjing 26
Toronto 24
Falls Church 21
Guangzhou 21
Ottawa 19
San Mateo 17
Hefei 16
Phoenix 15
Redwood City 13
Jinan 12
Kunming 12
Amsterdam 11
Hebei 11
Hong Kong 10
Washington 10
London 9
Chengdu 8
Mumbai 8
Shenyang 8
Cagliari 7
Paris 7
Shanghai 7
Velletri 7
Turin 6
Fiumicino 5
Indiana 5
Laurel 5
Nanchang 5
Perugia 5
Salerno 5
San Remo 5
Tappahannock 5
Vienna 5
Bern 4
Catania 4
Lappeenranta 4
Muizenberg 4
Palermo 4
Romainville 4
Southend 4
Torgiano 4
Wuhan 4
Agrigento 3
Auburn Hills 3
Avellino 3
Brindisi 3
Buffalo 3
Cinisello Balsamo 3
Edinburgh 3
Fiano Romano 3
Florence 3
Latina 3
Lima 3
Matelica 3
Montréal 3
Mülheim 3
Nettuno 3
Nuremberg 3
Parma 3
Redmond 3
Srpska 3
Warsaw 3
Zagreb 3
Zurich 3
Acton 2
Totale 7.448
Nome #
Bronchiolitis. Analysis of 10 consecutive epidemic seasons 130
Analysis of Th17 and Tc17 frequencies and antiviral defenses in gut-associated lymphoid tissue of chronic HIV-1 positive patients 116
Frequent detection of high human papillomavirus DNA loads in oral potentially malignant disorders 116
Bronchiolite da virus respiratorio sinciziale, bocavirus umano e rinovirus e "wheezing" dopo 24 mesi di follow-up 111
Usutu virus growth in human cell lines: induction of and sensitivity to type I and III interferons 103
Respiratory syncytial virus bronchiolitis, weather conditions and air pollution in an Italian urban area: An observational study 102
Analysis of the immune response in infants hospitalized with viral bronchiolitis shows different Th1/Th2 profiles associated with respiratory syncytial virus and human rhinovirus 101
Probiotics differently affect gut-associated lymphoid tissue indolamine-2, 3-dioxygenase mRNA and cerebrospinal fluid neopterin levels in antiretroviral-treated HIV-1 infected patients: A pilot study 99
Probiotic supplementation promotes a reduction in T-cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART-treated HIV-1-positive patients 99
SARS-CoV-2 Entry Genes Expression in Relation with Interferon Response in Cystic Fibrosis Patients 95
Risk Factors for Virus-Induced Acute Respiratory Tract Infections in Children Younger Than 3 Years and Recurrent Wheezing at 36 Months Follow-Up After Discharge 94
Cellular issues relating to the resistance of HIV to antiretroviral agents 94
Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19) 93
Challenges in the management of HIV infection. Update on the role of probiotic supplementation as a possible complementary therapeutic strategy for cART treated people living with HIV/AIDS 91
Respiratory syncytial virus 89
Differential interferon gene expression in bronchiolitis caused by respiratory syncytial virus-A genotype ON1 89
Bordetella pertussis in infants hospitalized for acute respiratory symptoms remains a concern 88
A pilot study on the effects of probiotic supplementation on neuropsychological performance and microRNA-29a-c levels in antiretroviral-treated HIV-1-infected patients 88
Twenty-five years of type I interferon-based treatment: A critical analysis of its therapeutic use 86
Interferon lambda receptor 1 (IFNL1R) transcript is highly expressed in rhinovirus bronchiolitis and correlates with disease severity 86
Challenges in the management of SARS-CoV2 infection. The role of oral bacteriotherapy as complementary therapeutic strategy to avoid the progression of COVID-19 86
Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients 85
Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients 85
Early Post-Transplant Torquetenovirus Viremia Predicts Cytomegalovirus Reactivations In Solid Organ Transplant Recipients 84
How Respiratory Syncytial Virus Genotypes Influence the Clinical Course in Infants Hospitalized for Bronchiolitis 84
Recently identified viruses contribute significantly to acute respiratory infections in children. 83
Bordetella Pertussis: come diagnosticarla nei bambini ricoverati per bronchiolite 83
ACE2 expression is related to the interferon response in airway epithelial cells but is that functional for SARS-CoV-2 entry? 82
Acute bronchiolitis: Influence of viral co-infection in infants hospitalized over 12 consecutive epidemic seasons 81
Cognitive impairment and CSF proteome modification after oral bacteriotherapy in HIV patients 81
Human immunodeficiency virus (HIV) DNA load and level of immunosuppression in treatment-naive hiv-1 infected patients 80
Persistence of a Large Population of Exhausted Monoclonal B cells in Mixed Cryoglobuliemia After the Eradication of Hepatitis C Virus Infection 79
No detection of SARS-CoV-2 in cystic fibrosis patients at the Regional (Lazio) Reference Center for CF in Italy 79
Alteration of type I interferon response is associated with subclinical atherosclerosis in virologically suppressed HIV-1-infected male patients 79
TLR9 is expressed in human papillomavirus-positive cervical cells and is overexpressed in persistent infections 78
Increased expression of IL-32 correlates with IFN-γ, Th1 and Tc1 in virologically suppressed HIV-1-infected patients 78
Antiviral activity of the interferon α family: biological and pharmacological aspects of the treatment of chronic hepatitis C. 77
Type I/II interferon in HIV-1-infected patients: expression in gut mucosa and in peripheral blood mononuclear cells and its modification upon probiotic supplementation 77
Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patients 77
CD38 modulates respiratory syncytial virus-driven proinflammatory processes in human monocyte-derived dendritic cells 76
Respiratory syncytial virus, human bocavirus and rhinovirus bronchiolitis in infants 75
Variation in interferon sensitivity and induction between Usutu and West Nile (lineages 1 and 2) viruses 75
Pharmacodynamics of interferon beta in multiple sclerosis patients with or without serum neutralizing antibodies 74
Rhinovirus frequently detected in elderly adults attending an emergency department 74
Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha. 73
Expression levels of TLRs involved in viral recognition in PBMCs from HIV-1-infected patients failing antiretroviral therapy 73
Antiviral activity of fecal water samples from HIV-1 infected subjects treated with a specific probiotic formulation 73
Consolidation of molecular testing in clinical virology 72
Increased SAMHD1 transcript expression correlates with interferon-related genes in HIV-1-infected patients 72
Impact of IFN lambda 3/4 single nucleotide polymorphisms on the cytomegalovirus reactivation in autologous stem cell transplant patients 71
IFN-stimulated gene expression is independent of the IFNL4 genotype in chronic HIV-1 infection 71
Increased IL-17 and/or IFN-γ producing T-cell subsets in gut mucosa of long-term-treated HIV-1-infected women 71
Determinants of reduced interferon gamma expression in severe respiratory syncytial virus disease: the authors respond 71
Antiviral Activity of the Combination of Interferon and Ribavirin Against Chikungunya Virus: Are the Results Conclusive? 70
Interferon-γ possesses anti-microbial and immunomodulatory activity on a Chlamydia Trachomatis infection model of primary human synovial fibroblasts 70
Elevated antinuclear antibodies and altered anti-Epstein-Barr virus immune responses. 69
null 69
Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome 69
Risk factors for recurrent wheezing following bronchiolitis : 3 years follow up. 69
Human bocavirus in children hospitalized for acute respiratory tract infection in Rome 69
Evaluation of interleukin 28B single nucleotide polymorphisms in infants suffering from bronchiolitis 68
Increased T-helper cell 2 response in infants with respiratory syncytial virus bronchiolitis hospitalized outside epidemic peak 68
A single centre study of viral community-acquired pneumonia in children: no evidence of SARSCoV-2 from october 2019 to march 2020 68
High abundance of genus Prevotella is associated with dysregulation of IFN-I and T cell response in HIV-1-infected patients 68
Type-specific human papillomavirus-DNA load in anal infection in HIV-positive men 67
MicroRNA-29 family expression and its relation to antiviral immune response and viro-immunological markers in HIV-1-infected patients 67
Treatment of SARS with human interferons. 66
null 66
Detection of respiratory viruses in the 2009 winter season in Rome: 2009 Influenza A (H1N1) complications in children and concomitant type 1 diabetes onset 65
KI and WU polyomavirus in respiratory samples of sars‐cov‐2 infected patients 65
Development and specificities of anti-interferon neutralizing antibodies in patients with chronic hepatitis C treated with pegylated interferon-α 64
Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection. A case report 64
High detection rate of human papillomavirus in anal brushings from women attending a proctology clinic 63
Occult hepatitis C virus infection in type II mixed cryoglobulinaemia 63
Interferon lambda 1 expression in cervical cells differs between low-risk and high-risk human papillomavirus-positive women 63
Incidence and predisposing factors for severe disease in previously healthy term infants experiencing their first episode of bronchiolitis 63
Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro 63
Interferon lambda 1-3 expression in infants hospitalized for RSV or HRV associated bronchiolitis 63
Neutralizing and binding antibodies to interferon beta in patients with multiple sclerosis: a comparison of assay results from three italian centres. 63
Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients 63
Fate of neutralizing and binding antibodies to IFN beta in MS patients treated with IFN beta for 6 years 62
Expression of biomarkers of interferon type I in patients suffering from chronic diseases 62
Lack of usutu virus RNA in cerebrospinal fluid of patients with encephalitis of unknown etiology, Tuscany, Italy 62
Molecular epidemiology and genetic diversity of human rhinovirus affecting hospitalized children in Rome 62
Standardization of human IL-29 (IFN-λ1): establishment of a World Health Organization international reference reagent for IL-29 (IFN-λ1). 62
Serum interferon (IFN)-neutralizing antibodies and bioactivities of IFNs in patients with severe type II essential mixed cryoglobulinemia 62
Evaluation of viral load in infants hospitalized with bronchiolitis caused by respiratory syncytial virus 62
BENEFICIAL EFFECT OF 6 MONTHS OF PROBIOTICS ON ASYMPTOMATIC NEUROCOGNITIVE IMPAIRMENT 61
INTERFERON-INDUCED GENE EXPRESSION IN CERVICAL MUCOSA DURING HUMAN PAPILLOMAVIRUS INFECTION 61
Short-Term Probiotic Administration Increases Fecal-Anti Candida Activity in Healthy Subjects 61
Distribution of Interferon Lambda 4 Single Nucleotide Polymorphism rs11322783 Genotypes in Patients with COVID-19 61
Neutralizing antibodies against endogenous interferon in myasthenia gravis patients 61
Severe Acute Respiratory Syndrome Coronavirus Elicits a Weak Interferon Response Compared to Traditional Interferon-Inducing Viruses 60
Dual effect of Thymosin α 1 on human monocyte-derived dendritic cellin vitrostimulated with viral and bacterial toll-like receptor agonists 60
Modulation of phenylalanine and tyrosine metabolism in HIV-1 infected patients with neurocognitive impairment: results from a clinical trial 60
Differential Toll like receptor expression in cystic fibrosis patients' airways during rhinovirus infection 59
Detection and typing by molecular techniques of respiratory viruses in children hospitalized for acute respiratory infection in Rome, Italy 59
CARATTERIZZAZIONE CLINICA E VIROLOGICA DEI GENOTIPI NA1 E ON1 DEL VIRUS RESPIRATORIO SINCIZIALE A (RSV-A) E DEL VIRUS RESPIRATORIO SINCIZIALE B (RSV-B) IN BAMBINI AFFETTI DA BRONCHIOLITE 58
Neutralizing antibodies to interferon alpha in a chronic hepatitis C patient non-responder to pegylated interferon 57
Human bocavirus infection in hospitalized children in Italy 57
Totale 7.523
Categoria #
all - tutte 27.161
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.161


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019832 0 0 0 0 0 0 0 0 27 179 344 282
2019/20202.266 268 69 29 95 200 434 377 255 223 132 111 73
2020/20211.169 116 116 39 89 33 162 61 82 110 226 83 52
2021/20222.136 42 111 168 76 214 64 79 198 211 126 501 346
2022/20232.248 391 456 130 272 227 216 38 179 172 29 94 44
2023/20241.092 81 187 107 146 125 183 93 150 20 0 0 0
Totale 10.560